AU6591396A - Id as a diagnostic marker in tumor cells - Google Patents

Id as a diagnostic marker in tumor cells

Info

Publication number
AU6591396A
AU6591396A AU65913/96A AU6591396A AU6591396A AU 6591396 A AU6591396 A AU 6591396A AU 65913/96 A AU65913/96 A AU 65913/96A AU 6591396 A AU6591396 A AU 6591396A AU 6591396 A AU6591396 A AU 6591396A
Authority
AU
Australia
Prior art keywords
tumor cells
diagnostic marker
marker
diagnostic
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65913/96A
Inventor
Robert Benezra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sloan Kettering Institute for Cancer Research
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU6591396A publication Critical patent/AU6591396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
AU65913/96A 1995-08-01 1996-07-19 Id as a diagnostic marker in tumor cells Abandoned AU6591396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US173595P 1995-08-01 1995-08-01
US001735 1995-08-01
PCT/US1996/012014 WO1997005283A1 (en) 1995-08-01 1996-07-19 Id AS A DIAGNOSTIC MARKER IN TUMOR CELLS

Publications (1)

Publication Number Publication Date
AU6591396A true AU6591396A (en) 1997-02-26

Family

ID=21697572

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65913/96A Abandoned AU6591396A (en) 1995-08-01 1996-07-19 Id as a diagnostic marker in tumor cells

Country Status (2)

Country Link
AU (1) AU6591396A (en)
WO (1) WO1997005283A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001041781A2 (en) * 1999-12-09 2001-06-14 Alcon Universal Ltd. Id protein inhibitors for treating ocular diseases
EP1356107A2 (en) * 2000-11-28 2003-10-29 Wyeth Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US7267951B2 (en) 2002-06-05 2007-09-11 Sloan-Kettering Institute For Cancer Research Method for evaluating a tissue or biopsy sample to determine if the sample is early-stage melanoma
KR20140068062A (en) 2011-09-15 2014-06-05 제넨테크, 인크. Methods of promoting differentiation

Also Published As

Publication number Publication date
WO1997005283A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
AU5934396A (en) Improved battery design
AU2916695A (en) Localizer
AU7612196A (en) Functional human hematopoietic cells
AU4898796A (en) Markers for use in screening patients
AU4818396A (en) Battery
AU6418498A (en) Human genes
AUPN112795A0 (en) Improvements in fertilisers
AU8696398A (en) Automated abrader
AU678952B2 (en) Multi-element battery
AU7218598A (en) Soil core collector
AU4656997A (en) Method for inhibiting tumor angiogenesis in a living subject
AU6591396A (en) Id as a diagnostic marker in tumor cells
AU1839995A (en) Spherical composter
GB9516556D0 (en) Cell culture laminate
AU4468897A (en) Topical preparation for introducing peptidaceous pharmacons in living organisms
AU7574396A (en) Improved composting methods
AU5545696A (en) Gene marker associated with swine proliferacy
AU1684197A (en) Dna markers for shrimp selection
AU2104497A (en) Cell stimulation
AU6377696A (en) Attachment enhanced 293 cells
AU9580398A (en) Atm exon 24 variant as a cancer marker
AUPN639195A0 (en) Agricultural implement
AU7434996A (en) A novel human b cell surface molecule
AU8746598A (en) Tissue collector
AU3026997A (en) Cell cultivation process